Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis

Marsh, S., McKay, J., Curran, S., Murray, G., Cassidy, J. and McLeod, H. (2002) Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncology Reports, 9(2), pp. 231-234.

Full text not currently available from Enlighten.

Abstract

Analysis of tumour markers is helping to predict individual patient response to chemotherapy. However, the difficulties in obtaining metastatic disease samples has led to a reliance on assessment of primary tumour, with little data on its predictive ability. This study assessed thymidylate synthase (TS), a target for the commonly used drug 5FU, in 42 paired primary colorectal tumour and lymph node metastasis. High TS staining was seen in 63% of primary colon tumour cells and 81% of the secondary lymph node. Primary tumour did not have significant predictive power for secondary tumour samples (?=0.125; p=0.38). There was no significant relationship between TS staining and expression of G1/S cell cycle proteins p21, p27, p53, cyclin D1, proliferating cell nuclear antigen (PCNA) and retinoblastoma protein (Rb) (p>0.05 in all cases). Discordance in TS protein levels between primary and secondary tumours demonstrates the danger of predicting outcome after chemotherapy in metastatic colorectal cancer from the primary tumour.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Cassidy, Professor James
Authors: Marsh, S., McKay, J., Curran, S., Murray, G., Cassidy, J., and McLeod, H.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Oncology Reports
ISSN:1021-335X

University Staff: Request a correction | Enlighten Editors: Update this record